640 related articles for article (PubMed ID: 25643988)
1. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis.
Hakalahti A; Biancari F; Nielsen JC; Raatikainen MJ
Europace; 2015 Mar; 17(3):370-8. PubMed ID: 25643988
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency catheter ablation maintains its efficacy better than antiarrhythmic medication in patients with paroxysmal atrial fibrillation: On-treatment analysis of the randomized controlled MANTRA-PAF trial.
Raatikainen MJ; Hakalahti A; Uusimaa P; Nielsen JC; Johannessen A; Hindricks G; Walfridsson H; Pehrson S; Englund A; Hartikainen J; Kongstad O; Mortensen LS; Hansen PS;
Int J Cardiol; 2015 Nov; 198():108-14. PubMed ID: 26163901
[TBL] [Abstract][Full Text] [Related]
3. Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation.
Elsayed M; Abdelfattah OM; Sayed A; Prasad RM; Barakat AF; Elgendy IY; Andrade J; Jared Bunch T; Thosani A; Saliba WI; Wazni OM; Hussein AA
J Cardiovasc Electrophysiol; 2022 Feb; 33(2):197-208. PubMed ID: 34855270
[TBL] [Abstract][Full Text] [Related]
4. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
[TBL] [Abstract][Full Text] [Related]
5. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials.
Turagam MK; Musikantow D; Whang W; Koruth JS; Miller MA; Langan MN; Sofi A; Choudry S; Dukkipati SR; Reddy VY
JAMA Cardiol; 2021 Jun; 6(6):697-705. PubMed ID: 33909022
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-analysis of Safety and Efficacy.
Yi F; Hou W; Zhou C; Yin Y; Lu S; Duan C; Cao M; Li M; Toft ES; Zhang H
J Cardiovasc Pharmacol; 2019 Apr; 73(4):241-247. PubMed ID: 30688797
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial.
Morillo CA; Verma A; Connolly SJ; Kuck KH; Nair GM; Champagne J; Sterns LD; Beresh H; Healey JS; Natale A;
JAMA; 2014 Feb; 311(7):692-700. PubMed ID: 24549549
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Catheter Ablation vs Antiarrhythmic Drugs as Initial Therapy for Management of Symptomatic Paroxysmal Atrial Fibrillation: A Meta-Analysis.
Razzack AA; Lak HM; Pothuru S; Rahman S; Hassan SA; Hussain N; Najeeb H; Reddy KT; Syeda H; Yasmin F; Mustafa A; Chawla S; Munir MB; Barakat AF; Saliba W; Wazni O; Hussein AA
Rev Cardiovasc Med; 2022 Mar; 23(3):112. PubMed ID: 35345279
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of cryoballoon ablation versus antiarrhythmic drugs as initial therapy for symptomatic atrial fibrillation.
Mao YJ; Feng WY; Huang QY; Yu FL; Chen JX; Wang H
Clin Cardiol; 2021 Oct; 44(10):1393-1401. PubMed ID: 34327708
[TBL] [Abstract][Full Text] [Related]
10. Indirect Comparison of Cryoablation and Radiofrequency Ablation as Initial Therapy for Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Mao YJ; Ai LJ; Cai YH; Huang QY; Yu FL; Chen JX; Huang PF; Wang H
Cardiology; 2023; 148(2):138-149. PubMed ID: 36596284
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
Nielsen JC; Johannessen A; Raatikainen P; Hindricks G; Walfridsson H; Pehrson SM; Englund A; Hartikainen J; Mortensen LS; Hansen PS;
Heart; 2017 Mar; 103(5):368-376. PubMed ID: 27566295
[TBL] [Abstract][Full Text] [Related]
12. Catheter ablation and antiarrhythmic drug therapy as first- or second-line therapy in the management of atrial fibrillation: systematic review and meta-analysis.
Khan AR; Khan S; Sheikh MA; Khuder S; Grubb B; Moukarbel GV
Circ Arrhythm Electrophysiol; 2014 Oct; 7(5):853-60. PubMed ID: 25110162
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study.
Pappone C; Vicedomini G; Augello G; Manguso F; Saviano M; Baldi M; Petretta A; Giannelli L; Calovic Z; Guluta V; Tavazzi L; Santinelli V
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):808-14. PubMed ID: 21946315
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials.
Chen W; Liu H; Ling Z; Xu Y; Fan J; Du H; Xiao P; Su L; Liu Z; Lan X; Zrenner B; Yin Y
PLoS One; 2016; 11(5):e0156121. PubMed ID: 27224469
[TBL] [Abstract][Full Text] [Related]
15. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study.
Khaykin Y; Wang X; Natale A; Wazni OM; Skanes AC; Humphries KH; Kerr CR; Verma A; Morillo CA
J Cardiovasc Electrophysiol; 2009 Jan; 20(1):7-12. PubMed ID: 18803564
[TBL] [Abstract][Full Text] [Related]
16. Catheter Ablation is Superior to Antiarrhythmic Drugs as First-Line Treatment for Atrial Fibrillation: a Systematic Review and Meta-Analysis.
Cardoso R; Justino GB; Graffunder FP; Benevides L; Knijnik L; Sanchez LMF; d'Avila A
Arq Bras Cardiol; 2022 Jul; 119(1):87-94. PubMed ID: 35830118
[TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of radiofrequency catheter ablation as first-line treatment for paroxysmal atrial fibrillation: results from a MANTRA-PAF substudy.
Aronsson M; Walfridsson H; Janzon M; Walfridsson U; Nielsen JC; Hansen PS; Johannessen A; Raatikainen P; Hindricks G; Kongstad O; Pehrson S; Englund A; Hartikainen J; Mortensen LS; Levin LÅ
Europace; 2015 Jan; 17(1):48-55. PubMed ID: 25341739
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis.
Chander S; Kumari R; Luhana S; Shiwlani S; Parkash O; Sorath F; Wang HY; Tan S; Rahaman Z; Mohammed YN; Lohana AC; Sakshi F; Vaish E; Sadarat F
BMC Cardiovasc Disord; 2024 Jun; 24(1):321. PubMed ID: 38918704
[TBL] [Abstract][Full Text] [Related]
19. Ablation for atrial fibrillation: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(7):1-63. PubMed ID: 23074498
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
